Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $28.29 in the prior trading day, DENTSPLY Sirona Inc (NASDAQ: XRAY) closed at $28.25, down -0.14%. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 4.23 million shares were traded. XRAY stock price reached its highest trading level at $28.62 during the session, while it also had its lowest trading level at $27.975.
Ratios:
Our goal is to gain a better understanding of XRAY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.02. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.57.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $42.
On November 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 22 ’23 when LUCIER GREGORY T bought 10,000 shares for $31.44 per share. The transaction valued at 314,400 led to the insider holds 43,121 shares of the business.
Coleman Glenn bought 10,000 shares of XRAY for $297,000 on Nov 20 ’23. The Executive VP & CFO now owns 73,566 shares after completing the transaction at $29.70 per share. On Nov 20 ’23, another insider, Campion Simon D, who serves as the President, CEO & Member of BOD of the company, bought 10,000 shares for $29.70 each. As a result, the insider paid 297,000 and bolstered with 243,930 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 5873881088 and an Enterprise Value of 7807563264. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49 while its Price-to-Book (P/B) ratio in mrq is 1.80. Its current Enterprise Value per Revenue stands at 1.982 whereas that against EBITDA is 12.452.
Stock Price History:
Over the past 52 weeks, XRAY has reached a high of $41.65, while it has fallen to a 52-week low of $26.27. The 50-Day Moving Average of the stock is -12.11%, while the 200-Day Moving Average is calculated to be -16.58%.
Shares Statistics:
The stock has traded on average 3.56M shares per day over the past 3-months and 2931680 shares per day over the last 10 days, according to various share statistics. A total of 207.20M shares are outstanding, with a floating share count of 205.59M. Insiders hold about 0.98% of the company’s shares, while institutions hold 104.71% stake in the company. Shares short for XRAY as of 1713139200 were 11933298 with a Short Ratio of 3.35, compared to 1710460800 on 10056710. Therefore, it implies a Short% of Shares Outstanding of 11933298 and a Short% of Float of 6.569999999999999.
Dividends & Splits
In the trailing 12 months, XRAY’s forward annual dividend rate was 0.58, compared to 0.58 this year. Against a Trailing Annual Dividend Yield of 0.020501943The stock’s 5-year Average Dividend Yield is 1.06.
